Paul V. Thomas is the Global Head of Portfolio Strategy and Program Management at Biocon Biologics, where Paul V. also serves as the Chief Commercial Officer for both the US division and the overall company. Before joining Biocon, Paul V. held positions at Pfizer, including Director of US Marketing for Rapamune and Senior Product Manager for Effexor XR. Paul has a diverse background that includes experience in strategic planning, business strategy, and project management across various industries and countries. Paul V. holds an MBA from The Wharton School and a BS in Civil and Environmental Engineering from Cornell University.
December, 2022 - present
December, 2019
April, 2018